75 related articles for article (PubMed ID: 25771143)
1. Rosuvastatin suppresses atrial tachycardia-induced cellular remodeling via Akt/Nrf2/heme oxygenase-1 pathway.
Yeh YH; Kuo CT; Chang GJ; Chen YH; Lai YJ; Cheng ML; Chen WJ
J Mol Cell Cardiol; 2015 May; 82():84-92. PubMed ID: 25771143
[TBL] [Abstract][Full Text] [Related]
2. Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothelium exposed to laminar shear stress and impaired by disturbed flow.
Ali F; Zakkar M; Karu K; Lidington EA; Hamdulay SS; Boyle JJ; Zloh M; Bauer A; Haskard DO; Evans PC; Mason JC
J Biol Chem; 2009 Jul; 284(28):18882-92. PubMed ID: 19457866
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles derived from HBMSCs improved myocardial infarction through inhibiting zinc finger antisense 1 and activating Akt/Nrf2/HO-1 pathway.
Xiao H; Wu D; Yang T; Fu W; Yang L; Hu C; Wan H; Hu X; Zhang C; Wu T
Bioengineered; 2022 Jan; 13(1):905-916. PubMed ID: 34974805
[TBL] [Abstract][Full Text] [Related]
4. Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/phosphoinositide 3-kinase/Akt-2 pathway.
Geraldes P; Yagi K; Ohshiro Y; He Z; Maeno Y; Yamamoto-Hiraoka J; Rask-Madsen C; Chung SW; Perrella MA; King GL
J Biol Chem; 2008 Dec; 283(49):34327-36. PubMed ID: 18854316
[TBL] [Abstract][Full Text] [Related]
5. Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling.
Beckwitt CH; Shiraha K; Wells A
PLoS One; 2018; 13(5):e0197422. PubMed ID: 29763460
[TBL] [Abstract][Full Text] [Related]
6. Rutin prevents EqHV-8 induced infection and oxidative stress via Nrf2/HO-1 signaling pathway.
Chen L; Li S; Li W; Yu Y; Sun Q; Chen W; Zhou H; Wang C; Li L; Xu M; Khan MZ; Li Y; Wang T
Front Cell Infect Microbiol; 2024; 14():1386462. PubMed ID: 38725448
[TBL] [Abstract][Full Text] [Related]
7. Dapagliflozin attenuates the vulnerability to atrial fibrillation in rats with lipopolysaccharide-induced myocardial injury.
Zhao X; Liu Y; Han X; Wang X; Qu C; Liu X; Yang B
Int Immunopharmacol; 2023 Dec; 125(Pt A):111038. PubMed ID: 38149574
[TBL] [Abstract][Full Text] [Related]
8. NanoUPLC-QTOF-MS/MS Determination of Major Rosuvastatin Degradation Products Generated by Gamma Radiation in Aqueous Solution.
Dončević L; Svetličić E; Hozić A; Mihaljević B; Jarmużek D; Tartaro Bujak I; Pluskota-Karwatka D; Ozdanovac L; Džeba I; Cindrić M
Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832942
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane reduces apoptosis and oncosis along with protecting liver injury-induced ischemic reperfusion by activating the Nrf2/ARE pathway.
Chi X; Zhang R; Shen N; Jin Y; Alina A; Yang S; Lin S
Hepatol Int; 2015 Apr; 9(2):321-9. PubMed ID: 25788192
[TBL] [Abstract][Full Text] [Related]
10. Myrosinase-treated glucoerucin is a potent inducer of the Nrf2 target gene heme oxygenase 1--studies in cultured HT-29 cells and mice.
Wagner AE; Sturm C; Piegholdt S; Wolf IM; Esatbeyoglu T; De Nicola GR; Iori R; Rimbach G
J Nutr Biochem; 2015 Jun; 26(6):661-6. PubMed ID: 25776458
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner.
Le NA; Diffenderfer MR; Thongtang N; Ooi EM; Barrett PH; Horvath KV; Dolnikowski GG; Asztalos BF; Schaefer EJ; Brown WV
Lipids; 2015 May; 50(5):447-58. PubMed ID: 25809021
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.
Rollefstad S; Ikdahl E; Hisdal J; Olsen IC; Holme I; Hammer HB; Smerud KT; Kitas GD; Pedersen TR; Kvien TK; Semb AG
Arthritis Rheumatol; 2015 Jul; 67(7):1718-28. PubMed ID: 25778850
[TBL] [Abstract][Full Text] [Related]
13. Naringin protects against anoxia/reoxygenation-induced apoptosis in H9c2 cells via the Nrf2 signaling pathway.
Chen RC; Sun GB; Wang J; Zhang HJ; Sun XB
Food Funct; 2015 Apr; 6(4):1331-44. PubMed ID: 25773745
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: short-term and long-term efficacy and safety results.
Barge-Caballero G; Barge-Caballero E; Marzoa-Rivas R; Paniagua-Martín MJ; Barrio-Rodríguez A; Naya-Leira C; Blanco-Canosa P; Grille-Cancela Z; Vázquez-Rodríguez JM; Crespo-Leiro MG
Transpl Int; 2015 Sep; 28(9):1034-41. PubMed ID: 25864881
[TBL] [Abstract][Full Text] [Related]
15. Sodium fluoride generates ROS and alters transcription of genes for xenobiotic metabolizing enzymes in adult zebrafish (Danio rerio) liver: expression pattern of Nrf2/Keap1 (INrf2).
Mukhopadhyay D; Srivastava R; Chattopadhyay A
Toxicol Mech Methods; 2015; 25(5):364-73. PubMed ID: 25798649
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis.
Garg N; Krishan P; Syngle A
Clin Rheumatol; 2015 Jun; 34(6):1065-71. PubMed ID: 25771851
[TBL] [Abstract][Full Text] [Related]
17. Newly diagnosed atrial fibrillation is an independent factor for future major adverse cardiovascular events.
Li CY; Lin CP; Lin YS; Wu LS; Chang CJ; Chu PH
PLoS One; 2015; 10(4):e0123211. PubMed ID: 25875922
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase inhibition and rosuvastatin-induced vascular protection in the setting of ischemia-reperfusion: A human in vivo study.
Kwong W; Liuni A; Zhou K; Parker JD
Vascul Pharmacol; 2015 Aug; 71():159-65. PubMed ID: 25869511
[TBL] [Abstract][Full Text] [Related]
19. Differences in the management of hypertension, diabetes mellitus and dyslipidemia between obesity classes.
Martínez-St John DR; Palazón-Bru A; Gil-Guillén VF; Sepehri A; Navarro-Cremades F; Orozco-Beltrán D; Carratalá-Munuera C; Cortés E; Rizo-Baeza MM
J Hum Hypertens; 2016 Jan; 30(1):7-10. PubMed ID: 25833705
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
